Vor Biopharma director granted 57K stock options
Vor Biopharma director Wouter Joustra received a stock option grant covering 57,162 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vor Biopharma director Wouter Joustra received a stock option grant covering 57,162 shares of common stock. The option has an exercise price of $14.09 per share and expires on June 10, 2036. One thirty-sixth of the award vests monthly starting July 11, 2026, contingent on continued service. Following this compensation-related grant, Joustra holds 57,162 options directly and there were no open-market buys or sales reported.
Insider Trade Summary
Grant/Award: 57,162 shares
Grant/Award
1 txn
Insider
Joustra Wouter
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 57,162 | $0.00 | $0.00 |
Holdings After Transaction:
Stock option (right to buy) — 57,162 contracts (Direct)
Footnotes (1)
- F1. One thirty-sixth of the shares subject to the option shall vest and become exercisable on July 11, 2026 and each month thereafter, subject to the Reporting Person's continued service through each such vesting date.
Key Figures
Option grant size: 57,162 options
Exercise price: $14.09 per share
Underlying shares: 57,162 shares
+3 more
6 metrics
Option grant size
57,162 options
Stock option (right to buy) granted to director
Exercise price
$14.09 per share
Strike price for common stock under the option
Underlying shares
57,162 shares
Common stock underlying the option grant
Post-grant derivative holdings
57,162 options
Total options held following the transaction
Vesting commencement
July 11, 2026
One thirty-sixth vests monthly from this date
Expiration date
June 10, 2036
Final expiration of the stock option grant
Key Terms
Stock option (right to buy), vesting, exercise price, expiration date, +2 more
6 terms
Stock option (right to buy) financial
"security_title: Stock option (right to buy)"
vesting financial
"shares subject to the option shall vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: 14.0900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-10T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common stock financial
"underlying_security_title: Common stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
grant/award acquisition financial
"transaction_action: grant/award acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Vor Biopharma (VOR) director Wouter Joustra report on this Form 4?
Wouter Joustra reported receiving a stock option grant for 57,162 shares of Vor Biopharma common stock. The options were awarded as compensation, not through open-market buying, and are held directly following the transaction.
What is the exercise price of Wouter Joustra’s Vor Biopharma stock options?
The granted stock options have an exercise price of $14.09 per share. This is the price at which Joustra can buy Vor Biopharma common stock if and when the options vest and he chooses to exercise them.
When do Wouter Joustra’s Vor Biopharma options start vesting and over what schedule?
One thirty-sixth of the option grant vests on July 11, 2026, then monthly thereafter. Vesting continues each month, subject to Joustra’s continued service through each vesting date, gradually making more options exercisable over time.
When do Wouter Joustra’s Vor Biopharma stock options expire?
The stock options expire on June 10, 2036. After this expiration date, any unexercised options become worthless, so they must vest and be exercised before that time to convert into common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
